Clare Peters-Libeu

Title: Clare Peters-Libeu: Innovator in Peptide Research

Introduction

Clare Peters-Libeu is a notable inventor based in Sebastopol, California. She has made significant contributions to the field of peptide research, particularly in the development of innovative compositions that have potential therapeutic applications. With a total of two patents to her name, Peters-Libeu's work focuses on addressing critical health issues related to amyloid plaque formation and apolipoprotein E.

Latest Patents

One of her latest patents is titled "Netrin loop peptide mimetics and uses thereof." This patent describes compositions that include a pentapeptide designed to alter APP signaling and switch APP processing from aberrant to normal. The compositions aim to mitigate amyloid plaque formation, which is crucial in the context of neurodegenerative diseases.

Another significant patent is "Antibody specific for apolipoprotein and methods of use thereof." This patent provides synthetic antibodies that target an epitope present on an apolipoprotein E polypeptide. These antibodies have various applications in treatment, diagnostics, and monitoring, showcasing the versatility of her research.

Career Highlights

Clare Peters-Libeu has worked with esteemed institutions such as the J. David Gladstone Institutes and the Buck Institute for Research on Aging. Her experience in these organizations has allowed her to collaborate with leading scientists and contribute to groundbreaking research in her field.

Collaborations

Some of her notable coworkers include Yadong Huang and Qin Xu. Their collaborative efforts have further advanced the research and development of innovative solutions in peptide technology.

Conclusion

Clare Peters-Libeu's contributions to peptide research and her innovative patents highlight her role as a significant inventor in the scientific community. Her work continues to pave the way for advancements in therapeutic applications related to amyloid plaque formation and apolipoprotein E.